Route of administration other than oral for concomitant me­di­cation [Bioanalytics]

posted by qualityassurance – 2020-02-04 12:28 (1812 d 17:37 ago) – Posting: # 21141
Views: 4,386

Hello all,

We have given concomitant medication to subjects during clinical phase and the route of administration was topical, local (eye drops), IV, IM.

Can anyone suggest me :confused::confused: if it is required to include these medications in concomitant medication experiment if the route of administration is other than oral (e.g. IV, topical, eye drops) during clinical phase?

Complete thread:

UA Flag
Activity
 Admin contact
23,363 posts in 4,906 threads, 1,679 registered users;
167 visitors (0 registered, 167 guests [including 10 identified bots]).
Forum time: 06:05 CET (Europe/Vienna)

The combination of some data and an aching desire
for an answer does not ensure that a reasonable answer
can be extracted from a given body of data.    John W. Tukey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5